Omeros (OMER) Return on Invested Capital (2026)
Omeros (OMER) posted Return on Invested Capital of 0.07% for Q1 2026.
Omeros (OMER) Return on Invested Capital (2026) Analysis & Trends
Omeros has reported Return on Invested Capital for 1 years, with the latest figure at 0.07% in Q1 2026.
- Quarterly Return on Invested Capital changed N/A year-over-year to 0.07% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.07% (changed N/A YoY) and the FY2025 annual result came in at 1.32%, down 28.0% from the prior year.
- Return on Invested Capital held at 0.07% in Q1 2026 per OMER's latest filing.
- Over five years, Return on Invested Capital peaked at 0.07% in Q1 2026 and troughed at 0.07% in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 0.04% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.00% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -0.05% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.35% |
| 10 | Omeros | 1.24 Bn | 1.24 Bn | 27.73 Mn | -0.03% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.03% |
| Mar 31, 2026 | -0.07% |